Not applicableStudy completedNCT00918892What this trial is testingAssessment of Candidate Protein Expression in Breast Cancer SpecimensWho this might be right forBreast Cancer Case Comprehensive Cancer Center 460
Testing effectiveness (Phase 2)Study completedNCT02028364What this trial is testingPet Imaging as a Biomarker in Hormone Refractory postmenopausaL WomenWho this might be right forBreast Cancer Jules Bordet Institute 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07102940What this trial is testingEfti in Patients With Hormone Receptor Positive/HER2-neg Breast CancerWho this might be right forBreast CancerHER 2 Negative Breast CancerHR Positive/HER-2 Negative Breast Cancer+1 more George Washington University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05868226What this trial is testingPRE-ISPY Phase I/II Oncology Platform ProgramWho this might be right forHER2-positive Breast CancerMetastatic CancerMetastatic Breast Cancer+29 more QuantumLeap Healthcare Collaborative 280
Early research (Phase 1)Ended earlyNCT06878248What this trial is testingAssess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer MetastaticLocally Advanced Breast Cancer (LABC)Malignant Neoplasm of Breast+3 more Calibr, a division of Scripps Research 10
Early research (Phase 1)Study completedNCT03251378What this trial is testingA Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast CancersWho this might be right forAdvanced Solid TumorsMetastatic Colon CancerMetastatic Breast Cancer+4 more Hutchison Medipharma Limited 129
Testing effectiveness (Phase 2)Ended earlyNCT04862143What this trial is testingPilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With FulvestrantWho this might be right forAdvanced Breast Cancer Novartis Pharmaceuticals 2
Testing effectiveness (Phase 2)Ended earlyNCT03931551What this trial is testingOlaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast CancerWho this might be right forAdvanced Breast Cancer MedSIR 5
Large-scale testing (Phase 3)Study completedNCT01547741What this trial is testingDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerWho this might be right forBreast Cancer NSABP Foundation Inc 4,242
Testing effectiveness (Phase 2)Looking for participantsNCT04923542What this trial is testingSRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain MetastasesWho this might be right forBrain MetastasesHR+ Metastatic Breast Cancer H. Lee Moffitt Cancer Center and Research Institute 31
Post-approval studies (Phase 4)UnknownNCT02089854What this trial is testingAdjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast CancerWho this might be right forFemale Breast Cancer Peking Union Medical College Hospital 800
Large-scale testing (Phase 3)Study completedNCT00288002What this trial is testingCombination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast CancerWho this might be right forBreast Cancer GBG Forschungs GmbH 1,500
Not applicableActive Not RecruitingNCT07692230What this trial is testingMRI-Driven Precision Typing and Response Prediction in Luminal Breast CancerWho this might be right forHR Positive/HER-2 Negative Breast Cancer Fudan University 2,000
Not applicableStudy completedNCT06676436What this trial is testingObservational Study on the Treatment of Patients With Metastatic Breast CancerWho this might be right forCancer AstraZeneca 204
Not applicableStudy completedNCT06363812What this trial is testingProbability of OncotypeDx to Reallocate As Low or High Risk of Recurrence Breast Cancer Patients with Uncertain BiologyWho this might be right forBreast Cancer Fondazione Sandro Pitigliani 258
Large-scale testing (Phase 3)UnknownNCT05861830What this trial is testingDalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)Who this might be right forAdvanced Breast Cancer Peking Union Medical College Hospital 80
Large-scale testing (Phase 3)Looking for participantsNCT05063136What this trial is testingAdjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast CancerWho this might be right forBreast Cancer Henan Cancer Hospital 1,979
Not applicableStudy completedNCT04460898What this trial is testingRW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.Who this might be right forBreast Cancer Pfizer 195
Large-scale testing (Phase 3)Active Not RecruitingNCT03820830What this trial is testingPalbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast CancerWho this might be right forBreast Cancer Recurrent ETOP IBCSG Partners Foundation 405
Early research (Phase 1)Ended earlyNCT02964507What this trial is testingDose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast CancerWho this might be right forNeoplasms GlaxoSmithKline 124